From Diagnosis to Recovery: Akash Prasad’s Battle with MPS I
In this video, Akash Prasad, a 22-year-old, shares his journey with MPS I, a rare genetic disorder that affects growth and cognitive development. At 1.5 years old, Akash underwent emergency surgery for hernia and appendicitis. Following this, a doctor recommended further testing in Vellore, where Akash was diagnosed with MPS I in 2009. He experienced joint pain, stiffness, and delayed growth. Since being diagnosed, Akash has been receiving treatment and medication, which has greatly improved his condition. He has been receiving regular treatment since 2015 and now leads a normal life.
ΜΑΓ-ΙΝ-230106
leave-site-modal-text
You are now being redirected to a third-party website.
Sanofi does not endorse or approve the content, products, services or opinions on the third-party website. Sanofi shall not be responsible or in any way liable for any injury or damage to any persons in view of any reliance placed on or action taken basis of the information on the third party website or any errors, omissions or inaccuracies and/or incompleteness of the information on the third party website.
Right answer: Both A and B. As per Diabetic & Ramadan guidelines, T2DM patients can safely continue glargine U-100 once daily at a reduced dose of 15 - 30% at Iftar1,2. Insulin glargine U-100 is safe to be used during Ramadan with no significant increase in hypoglycaemia3. One-on-one dietary educational session can also reduce the number of adverse events of fasting1.
